Annual Drug Patent Expirations for SUBLOCADE
Sublocade is a drug marketed by Indivior and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for SUBLOCADE.
This drug has fifty-one patent family members in thirty-one countries.
The generic ingredient in SUBLOCADE is buprenorphine. One supplier is listed for this compound. Additional details are available on the buprenorphine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
